Back

Untargeted-metabolomics identifies key metabolites for atrial fibrosis and recurrence of atrial fibrillation indication across populations

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: phenotyping and risk prediction Defining Types of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ming Chu

Jiangsu Province Hospital, Nanjing (China)

6 More presentations in this session

Presentation thumbnail
Deep learning-based detection of paroxysmal atrial fibrillation from sinus rhythm electrocardiograms and its association with stroke risk
Doctor Y. Na (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Dynamic changes in liver fibrosis and the risk of death and bleeding in non-cirrhotic patients with atrial fibrillation treated with NOACs.
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Identification of new atrial fibrillation phenotypes from insertable cardiac monitor recordings using unsupervised machine learning
Doctor E. Flo Lenz (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
The prognostic value of sinus rhythm restoration in patients hospitalized for atrial fibrillation
Doctor A. Samaras (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Head-to-head comparison of CHADS₂, CHA₂DS₂-VASc, CHA₂DS₂-VA, HAS-BLED, and HELT-E₂S₂ scores in edoxaban treated atrial fibrillation patients: a 2-year analysis from the ETNA-AF Global program
Doctor C. Wang (Taipei, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: phenotyping and risk prediction

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Simultaneous metabolomics analysis of atrial tissue, pericardial fluid and blood reveal novel metabolite signatures of the pathophysiology and biomarkers related to permanent atrial fibrillation
27 August 2022
thumbnail
Congress Presentation
AI-enabled ECG AF risk score as a predictor of early recurrence and AF burden after ablation
12 April 2026
thumbnail
Congress Presentation
Pharmacological cardioversion as a predictor of left atrial scarring in patients undergoing catheter ablation for persistent atrial fibrillation
12 April 2026
thumbnail
Congress Presentation
microRNAs as the predictors for atrial fibrillation recurrence after catheter ablation: next-generation sequencing study
5 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources